Prediction of BRCA1 germline mutation status in women with ovarian cancer using morphology-based criteria: Identification of a BRCA1 ovarian cancer phenotype

American Journal of Surgical Pathology

Volumn 36, Issue 8, 2012, Pages 1170-1177

  Fujiwara, Mika ^a   McGuire, Valerie A ^a   Felberg, Anna ^a   Sieh, Weiva ^a   Whittemore, Alice S ^a   Longacre, Teri A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; germline mutation; morphology; ovarian cancer; serous

Indexed keywords

BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN;

ADULT; ARTICLE; FEMALE; GENETICS; HUMAN; MIDDLE AGED; MUTATION; OVARY TUMOR; PATHOLOGY; PHENOTYPE; SENSITIVITY AND SPECIFICITY;

ADULT; BRCA1 PROTEIN; FEMALE; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PHENOTYPE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84863836600     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31825d9b8d     Document Type: Article

References (38)

1. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62:676-689. (Pubitemid 28164626)
2. Claus EB, Schildkraut JM, Thompson WD, et al. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996;77: 2318-2324. (Pubitemid 26162426)
3. Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. 2001;68:700-710. (Pubitemid 32203724)
4. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet. 1997;349:1505-1510.
5. Armes JE, Egan AJ, Southey MC, et al. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: A populationbased study. Cancer. 1998;83:2335-2345. (Pubitemid 28533503)
6. Armes JE, Venter DJ. The pathology of inherited breast cancer. Pathology. 2002;34:309-314. (Pubitemid 34827990)
7. Da Silva L, Lakhani SR. Pathology of hereditary breast cancer. Mod Pathol. 2010;23(suppl 2):S46-S51.
8. Farshid G, Balleine RL, Cummings M, et al. Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing. Am J Surg Pathol. 2006;30:1357-1366. (Pubitemid 44655468)
9. Gadzicki D, Schubert A, Fischer C, et al. Histopathological criteria and selection algorithms for BRCA1 genetic testing. Cancer Genet Cytogenet. 2009;189:105-111.
10. Lidereau R, Eisinger F, Champeme MH, et al. Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res. 2000;60:1206-1210. (Pubitemid 30151984)
11. Longacre TA, Oliva E, Soslow RA. Recommendations for the reporting of fallopian tube neoplasms. Hum Pathol. 2007;38: 1160-1163.
12. Tonin PN, Maugard CM, Perret C, et al. A review of histopathological subtypes of ovarian cancer in BRCA-related french canadian cancer families. Fam Cancer. 2007;6:491-497. (Pubitemid 47622264)
13. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report. Atlanta, GA: Department of Health and Human Services; 2011.
14. Werness BA, Ramus SJ, DiCioccio RA, et al. Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Int J Gynecol Pathol. 2004;23:29-34. (Pubitemid 38018234)
15. Folkins AK, Jarboe EA, Saleemuddin A, et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol. 2008;109:168-173.
16. Lavie O, Hornreich G, Ben-Arie A, et al. BRCA germline mutations in jewish women with uterine serous papillary carcinoma. Gynecol Oncol. 2004;92:521-524. (Pubitemid 38183139)
17. McGuire V, Felberg A, Mills M, et al. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. Am J Epidemiol. 2004;160:613-618. (Pubitemid 39281840)
18. Orita M, Iwahana H, Kanazawa H, et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA. 1989;86: 2766-2770. (Pubitemid 19112622)
19. Tworek H, Peng R, Fetzer S, et al. Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors. Cancer Genet Cytogenet. 1999;112:105-118. (Pubitemid 29322732)
20. Shimizu Y, Kamoi S, Amada S, et al. Toward the development of a universal grading system for ovarian epithelial carcinoma: Testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer. 1998;82:893-901. (Pubitemid 28104169)
21. Soslow RA, Han G, Park KJ, et al. Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Mod Pathol. 2012;25:625-636.
22. Roh MH, Kindelberger D, Crum CP. Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Am J Surg Pathol. 2009;33:376-383.
23. Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD; http://seer.cancer.gov/csr/1975-2009-pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.
24. Agoff SN, Mendelin JE, Grieco VS, et al. Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or-2 mutations: Implications for gross examination, cytology, and clinical follow-up. Am J Surg Pathol. 2002;26:171-178. (Pubitemid 34127496)
25. Colgan TJ, Murphy J, Cole DE, et al. Occult carcinoma in prophylactic oophorectomy specimens: Prevalence and association with BRCA germline mutation status. Am J Surg Pathol. 2001;25: 1283-1289. (Pubitemid 32917122)
26. Prat J, Ribe A, Gallardo A. Hereditary ovarian cancer. Hum Pathol. 2005;36:861-870. (Pubitemid 41187904)
27. Rabban JT, Krasik E, Chen LM, et al. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingooophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol. 2009;33:1878-1885.
28. Tan DS, Rothermundt C, Thomas K, et al. "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol. 2008;26:5530-5536.
29. Young SR, Pilarski RT, Donenberg T, et al. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer. 2009;9:86.
30. Peshkin BN, Alabek ML, Isaacs C. BRCA1/2 mutations and triple negative breast cancers. Breast Dis. 2010;32:25-33.
31. Lancaster JM, Powell CB, Kauff ND, et al. Society of gynecologic oncologists education committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2007;107:159-162. (Pubitemid 47575743)
32. Neri A, Rabinerson D, Kaplan B, et al. Hereditary ovarian cancer. Isr J Med Sci. 1995;31:172-175.
33. Shaw PA, McLaughlin JR, Zweemer RP, et al. Histopathologic features of genetically determined ovarian cancer. Int J Gynecol Pathol. 2002;21:407-411.
34. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004;28: 496-504. (Pubitemid 38436523)
35. Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433-443.
36. Boyd J, Sonoda Y, Federici MG, et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA. 2000;283:2260-2265. (Pubitemid 30246777)
37. Lakhani SR, Manek S, Penault-Llorca F, et al. Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clin Cancer Res. 2004;10: 2473-2481. (Pubitemid 38445709)
38. Werness BA, Ramus SJ, Whittemore AS, et al. Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations. Hum Pathol. 2000;31:1420-1424.